Lim SY et al. |
Enhancing Human Cardiomyocyte Differentiation from Induced Pluripotent Stem Cells with Trichostatin A. |
2016 |
Methods Mol. Biol. |
pmid:25520285
|
Kishigami S and Wakayama T |
Somatic cell nuclear transfer in the mouse. |
2009 |
Methods Mol. Biol. |
pmid:19085136
|
Ishihara K |
Eosinophil cell lines. |
2014 |
Methods Mol. Biol. |
pmid:24986606
|
Unruhe-Knauf B and Knauer SK |
Analysis of HDACi-Induced Changes in Chromosomal Passenger Complex Localization. |
2017 |
Methods Mol. Biol. |
pmid:27761812
|
Liu C and Xu D |
Inhibition of histone deacetylases. |
2004 |
Methods Mol. Biol. |
pmid:15273406
|
Garfinkel MD et al. |
Multigenerational selection and detection of altered histone acetylation and methylation patterns: toward a quantitative epigenetics in Drosophila. |
2004 |
Methods Mol. Biol. |
pmid:15273410
|
Flørenes VA et al. |
Deacetylase inhibition in malignant melanomas: impact on cell cycle regulation and survival. |
2004 |
Melanoma Res. |
pmid:15179185
|
Martini M et al. |
Postmitotic Expression of SOD1(G93A) Gene Affects the Identity of Myogenic Cells and Inhibits Myoblasts Differentiation. |
2015 |
Mediators Inflamm. |
pmid:26491230
|
Mitchell MD et al. |
Epigenetic regulation of cytokine production in human amnion and villous placenta. |
2012 |
Mediators Inflamm. |
pmid:22665947
|
Hsing CH et al. |
Histone Deacetylase Inhibitor Trichostatin A Ameliorated Endotoxin-Induced Neuroinflammation and Cognitive Dysfunction. |
2015 |
Mediators Inflamm. |
pmid:26273133
|
Liu J et al. |
DNA promoter and histone H3 methylation downregulate NGX6 in gastric cancer cells. |
2014 |
Med. Oncol. |
pmid:24338274
|
Bezecny P |
Histone deacetylase inhibitors in glioblastoma: pre-clinical and clinical experience. |
2014 |
Med. Oncol. |
pmid:24838514
|
Böger H and Gruss P |
Functional determinants for the tetracycline-dependent transactivator tTA in transgenic mouse embryos. |
1999 |
Mech. Dev. |
pmid:10381574
|
Bauer I et al. |
A Class 1 Histone Deacetylase with Potential as an Antifungal Target. |
2016 |
MBio |
pmid:27803184
|
Hennig D et al. |
Novel insights into appropriate encapsulation methods for bioactive compounds into polymers: a study with peptides and HDAC inhibitors. |
2014 |
Macromol Biosci |
pmid:23966296
|
Hauff KD et al. |
Mifepristone treatment results in differential regulation of glycerolipid biosynthesis in baby hamster kidney cells expressing a mifepristone-inducible ABCA1. |
2011 |
Lipids |
pmid:21710238
|
Yang J et al. |
[Study of RASSF1A expression and promoter demethylation in Hep-2 cell line]. |
2011 |
Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi |
pmid:21473137
|
Wang J et al. |
Fungal metabolite myriocin promotes human herpes simplex virus-2 infection. |
2015 |
Life Sci. |
pmid:25447452
|
Ishihara K et al. |
Differentiation of eosinophilic leukemia EoL-1 cells into eosinophils induced by histone deacetylase inhibitors. |
2007 |
Life Sci. |
pmid:17258775
|
Yao J et al. |
ERK inhibition enhances TSA-induced gastric cancer cell apoptosis via NF-κB-dependent and Notch-independent mechanism. |
2012 |
Life Sci. |
pmid:22781708
|
Huang HC et al. |
Geldanamycin inhibits trichostatin A-induced cell death and histone H4 hyperacetylation in COS-7 cells. |
2002 |
Life Sci. |
pmid:12002521
|
Yang W et al. |
Trichostatin A increases the levels of plasma gelsolin and amyloid beta-protein in a transgenic mouse model of Alzheimer's disease. |
2014 |
Life Sci. |
pmid:24486299
|
Rios EC et al. |
The role of nitric oxide in the epigenetic regulation of THP-1 induced by lipopolysaccharide. |
2016 |
Life Sci. |
pmid:26826317
|
Motawi TK et al. |
Combinatorial strategy of epigenetic and hormonal therapies: A novel promising approach for treating advanced prostate cancer. |
2018 |
Life Sci. |
pmid:29455003
|
Lasa A et al. |
MEIS 1 expression is downregulated through promoter hypermethylation in AML1-ETO acute myeloid leukemias. |
2004 |
Leukemia |
pmid:15103390
|
Roddie PH et al. |
Primary acute myeloid leukaemia blasts resistant to cytokine-induced differentiation to dendritic-like leukaemia cells can be forced to differentiate by the addition of bryostatin-1. |
2002 |
Leukemia |
pmid:11840267
|
Kato N et al. |
Regulation of the expression of MHC class I-related chain A, B (MICA, MICB) via chromatin remodeling and its impact on the susceptibility of leukemic cells to the cytotoxicity of NKG2D-expressing cells. |
2007 |
Leukemia |
pmid:17625602
|
Bradbury CA et al. |
Histone deacetylases in acute myeloid leukaemia show a distinctive pattern of expression that changes selectively in response to deacetylase inhibitors. |
2005 |
Leukemia |
pmid:16121216
|
Kosugi H et al. |
Histone deacetylase inhibitors are the potent inducer/enhancer of differentiation in acute myeloid leukemia: a new approach to anti-leukemia therapy. |
1999 |
Leukemia |
pmid:10482980
|
Shaker S et al. |
Preclinical evaluation of antineoplastic activity of inhibitors of DNA methylation (5-aza-2'-deoxycytidine) and histone deacetylation (trichostatin A, depsipeptide) in combination against myeloid leukemic cells. |
2003 |
Leuk. Res. |
pmid:12620295
|
Balsas P et al. |
Bortezomib resistance in a myeloma cell line is associated to PSMβ5 overexpression and polyploidy. |
2012 |
Leuk. Res. |
pmid:21978467
|
Berg T et al. |
Reversal of p15/INK4b hypermethylation in AML1/ETO-positive and -negative myeloid leukemia cell lines. |
2007 |
Leuk. Res. |
pmid:17056112
|
Ryningen A et al. |
Clonogenic acute myelogenous leukemia cells are heterogeneous with regard to regulation of differentiation and effect of epigenetic pharmacological targeting. |
2007 |
Leuk. Res. |
pmid:17416413
|
Brown CO et al. |
Scavenger receptor class A member 3 (SCARA3) in disease progression and therapy resistance in multiple myeloma. |
2013 |
Leuk. Res. |
pmid:23537707
|
Robert C et al. |
Histone deacetylase inhibitors decrease NHEJ both by acetylation of repair factors and trapping of PARP1 at DNA double-strand breaks in chromatin. |
2016 |
Leuk. Res. |
pmid:27064363
|
Hammond SM et al. |
Negative regulatory elements are present in the human LMO2 oncogene and may contribute to its expression in leukemia. |
2005 |
Leuk. Res. |
pmid:15541480
|
Bouzelfen A et al. |
Heterogeneous epigenetic regulation of HACE1 in Burkitt- Lymphoma-derived cells. |
2017 |
Leuk. Res. |
pmid:28651105
|
Scott SA et al. |
5-Aza-2'-deoxycytidine (decitabine) can relieve p21WAF1 repression in human acute myeloid leukemia by a mechanism involving release of histone deacetylase 1 (HDAC1) without requiring p21WAF1 promoter demethylation. |
2006 |
Leuk. Res. |
pmid:16043219
|
Serrano E et al. |
Epigenetic-based treatments emphasize the biologic differences of core-binding factor acute myeloid leukemias. |
2008 |
Leuk. Res. |
pmid:18206229
|
Ondrousková E et al. |
A proteomic analysis of protein variations during differentiation of v-myb-transformed monoblasts. |
2007 |
Leuk. Res. |
pmid:16930693
|
Ninios YP et al. |
Differential sensitivity of human leukemic cell lines to the histone deacetylase inhibitor, trichostatin A. |
2010 |
Leuk. Res. |
pmid:19782399
|
Rohner A et al. |
Differentiation-promoting drugs up-regulate NKG2D ligand expression and enhance the susceptibility of acute myeloid leukemia cells to natural killer cell-mediated lysis. |
2007 |
Leuk. Res. |
pmid:17391757
|
Peng CY et al. |
Growth-inhibiting effects of arsenic trioxide plus epigenetic therapeutic agents on leukemia cell lines. |
2010 |
Leuk. Lymphoma |
pmid:20038232
|
Boehrer S et al. |
In the erythroleukemic cell line HEL Prostate-apoptosis-response-gene-4 (par-4) fails to down-regulate Bcl-2 and to promote apoptosis. |
2004 |
Leuk. Lymphoma |
pmid:15359646
|
Iijima K et al. |
Granulocytic differentiation of leukemic cells with t(9;11)(p22;q23) induced by all-trans-retinoic acid. |
2004 |
Leuk. Lymphoma |
pmid:15291362
|
Hawk JD et al. |
Post-training intrahippocampal inhibition of class I histone deacetylases enhances long-term object-location memory. |
2011 |
Learn. Mem. |
pmid:21576516
|
Gehring KB et al. |
Involvement of phosphorylated Apis mellifera CREB in gating a honeybee's behavioral response to an external stimulus. |
2016 |
Learn. Mem. |
pmid:27084927
|
Federman N et al. |
Histone acetylation is recruited in consolidation as a molecular feature of stronger memories. |
2009 |
Learn. Mem. |
pmid:19794185
|
Anderson I |
Deacetylase inhibitors aid recovery in muscular dystrophy. |
2006 |
Lancet Neurol |
pmid:17089447
|
Chou JL et al. |
Promoter hypermethylation of FBXO32, a novel TGF-beta/SMAD4 target gene and tumor suppressor, is associated with poor prognosis in human ovarian cancer. |
2010 |
Lab. Invest. |
pmid:20065949
|
Sakuma Y et al. |
WZ4002, a third-generation EGFR inhibitor, can overcome anoikis resistance in EGFR-mutant lung adenocarcinomas more efficiently than Src inhibitors. |
2012 |
Lab. Invest. |
pmid:22157722
|
Kondo T et al. |
Epigenetic silencing of TTF-1/NKX2-1 through DNA hypermethylation and histone H3 modulation in thyroid carcinomas. |
2009 |
Lab. Invest. |
pmid:19506552
|
Nakayama T et al. |
Epigenetic regulation of androgen receptor gene expression in human prostate cancers. |
2000 |
Lab. Invest. |
pmid:11140692
|
Fujisawa K et al. |
Epigenetic status and aberrant expression of the maspin gene in human hepato-biliary tract carcinomas. |
2005 |
Lab. Invest. |
pmid:15608662
|
Rogier E et al. |
A novel biological assay to detect the active form of TGF-beta in urine to monitor renal allograft rejection. |
2005 |
Kidney Int. |
pmid:16164666
|
Fan LX et al. |
Inhibition of histone deacetylases targets the transcription regulator Id2 to attenuate cystic epithelial cell proliferation. |
2012 |
Kidney Int. |
pmid:21900881
|
Lin W et al. |
Klotho restoration via acetylation of Peroxisome Proliferation-Activated Receptor γ reduces the progression of chronic kidney disease. |
2017 |
Kidney Int. |
pmid:28416226
|
Ranganathan P et al. |
Histone deacetylase–mediated silencing of AMWAP expression contributes to cisplatin nephrotoxicity. |
2016 |
Kidney Int. |
pmid:26509586
|
Nishikiori N et al. |
Prevention of murine experimental corneal trauma by epigenetic events regulating claudin 6 and claudin 9. |
2008 May-Jun |
Jpn. J. Ophthalmol. |
pmid:18661270
|
Karasawa Y and Okisaka S |
Inhibition of histone deacetylation by butyrate induces morphological changes in Y79 retinoblastoma cells. |
2004 Nov-Dec |
Jpn. J. Ophthalmol. |
pmid:15592778
|
Sekita N et al. |
Epigenetic regulation of the KAI1 metastasis suppressor gene in human prostate cancer cell lines. |
2001 |
Jpn. J. Cancer Res. |
pmid:11572762
|
Kosugi H et al. |
In vivo effects of a histone deacetylase inhibitor, FK228, on human acute promyelocytic leukemia in NOD / Shi-scid/scid mice. |
2001 |
Jpn. J. Cancer Res. |
pmid:11376562
|
Yoshida M |
[Discovery of cell cycle inhibitors and their application to molecular biology]. |
1999 |
Jpn J Antibiot |
pmid:10221182
|
Fan S et al. |
Valproic acid enhances gene expression from viral gene transfer vectors. |
2005 |
J. Virol. Methods |
pmid:15737413
|
Ye J et al. |
De novo protein synthesis is required for lytic cycle reactivation of Epstein-Barr virus, but not Kaposi's sarcoma-associated herpesvirus, in response to histone deacetylase inhibitors and protein kinase C agonists. |
2007 |
J. Virol. |
pmid:17596302
|
Fernandez G et al. |
Targeting IκB proteins for HIV latency activation: the role of individual IκB and NF-κB proteins. |
2013 |
J. Virol. |
pmid:23365428
|
Kim SY et al. |
Glial cell-specific regulation of the JC virus early promoter by histone deacetylase inhibitors. |
2003 |
J. Virol. |
pmid:12610114
|
Shin HJ et al. |
Histone deacetylase classes I and II regulate Kaposi's sarcoma-associated herpesvirus reactivation. |
2014 |
J. Virol. |
pmid:24227836
|
Gradoville L et al. |
Protein kinase C-independent activation of the Epstein-Barr virus lytic cycle. |
2002 |
J. Virol. |
pmid:11991990
|
Merezak C et al. |
Inhibition of histone deacetylases induces bovine leukemia virus expression in vitro and in vivo. |
2002 |
J. Virol. |
pmid:11967319
|
Arthur JL et al. |
Herpes simplex virus type 1 promoter activity during latency establishment, maintenance, and reactivation in primary dorsal root neurons in vitro. |
2001 |
J. Virol. |
pmid:11264377
|
Katz RA et al. |
High-frequency epigenetic repression and silencing of retroviruses can be antagonized by histone deacetylase inhibitors and transcriptional activators, but uniform reactivation in cell clones is restricted by additional mechanisms. |
2007 |
J. Virol. |
pmid:17202206
|
Quivy V et al. |
Synergistic activation of human immunodeficiency virus type 1 promoter activity by NF-kappaB and inhibitors of deacetylases: potential perspectives for the development of therapeutic strategies. |
2002 |
J. Virol. |
pmid:12368351
|
Countryman JK et al. |
Histone hyperacetylation occurs on promoters of lytic cycle regulatory genes in Epstein-Barr virus-infected cell lines which are refractory to disruption of latency by histone deacetylase inhibitors. |
2008 |
J. Virol. |
pmid:18337569
|
Génin P et al. |
Impairment of interferon-induced IRF-7 gene expression due to inhibition of ISGF3 formation by trichostatin A. |
2003 |
J. Virol. |
pmid:12768031
|
Lu F et al. |
Chromatin remodeling of the Kaposi's sarcoma-associated herpesvirus ORF50 promoter correlates with reactivation from latency. |
2003 |
J. Virol. |
pmid:14557628
|
Tsai PF et al. |
Interplay between PKCδ and Sp1 on histone deacetylase inhibitor-mediated Epstein-Barr virus reactivation. |
2011 |
J. Virol. |
pmid:21159880
|
Radkov SA et al. |
Epstein-Barr virus nuclear antigen 3C interacts with histone deacetylase to repress transcription. |
1999 |
J. Virol. |
pmid:10364319
|
Zhao W et al. |
Trichostatin A up-regulates human papillomavirus type 11 upstream regulatory region-E6 promoter activity in undifferentiated primary human keratinocytes. |
1999 |
J. Virol. |
pmid:10233965
|
Zhou L et al. |
Inhibition of Histone Deacetylase Activity Aggravates Coxsackievirus B3-Induced Myocarditis by Promoting Viral Replication and Myocardial Apoptosis. |
2015 |
J. Virol. |
pmid:26269170
|
Shestakova E et al. |
Inhibition of histone deacetylation induces constitutive derepression of the beta interferon promoter and confers antiviral activity. |
2001 |
J. Virol. |
pmid:11238870
|
Meier JL |
Reactivation of the human cytomegalovirus major immediate-early regulatory region and viral replication in embryonal NTera2 cells: role of trichostatin A, retinoic acid, and deletion of the 21-base-pair repeats and modulator. |
2001 |
J. Virol. |
pmid:11160656
|
Terry-Allison T et al. |
Relaxed repression of herpes simplex virus type 1 genomes in Murine trigeminal neurons. |
2007 |
J. Virol. |
pmid:17855552
|
Lu H et al. |
Tax relieves transcriptional repression by promoting histone deacetylase 1 release from the human T-cell leukemia virus type 1 long terminal repeat. |
2004 |
J. Virol. |
pmid:15194748
|
Oh HJ et al. |
Trichostatin a improves preimplantation development of bovine cloned embryos and alters expression of epigenetic and pluripotency genes in cloned blastocysts. |
2012 |
J. Vet. Med. Sci. |
pmid:22785124
|
Kang H and Roh S |
Extended exposure to trichostatin A after activation alters the expression of genes important for early development in nuclear transfer murine embryos. |
2011 |
J. Vet. Med. Sci. |
pmid:21187677
|
Kitamura H et al. |
Down-regulation of HLA class I antigens in prostate cancer tissues and up-regulation by histone deacetylase inhibition. |
2007 |
J. Urol. |
pmid:17574613
|
Jeon HG et al. |
Induction of caspase mediated apoptosis and down-regulation of nuclear factor-κB and Akt signaling are involved in the synergistic antitumor effect of gemcitabine and the histone deacetylase inhibitor trichostatin A in human bladder cancer cells. |
2011 |
J. Urol. |
pmid:21944112
|
Yoon CY et al. |
The histone deacetylase inhibitor trichostatin A synergistically resensitizes a cisplatin resistant human bladder cancer cell line. |
2011 |
J. Urol. |
pmid:21255805
|
Maxhimer JB et al. |
Induction of apoptosis of lung and esophageal cancer cells treated with the combination of histone deacetylase inhibitor (trichostatin A) and protein kinase C inhibitor (calphostin C). |
2005 |
J. Thorac. Cardiovasc. Surg. |
pmid:15632825
|
Archer SY et al. |
p21 gene regulation during enterocyte differentiation. |
2001 |
J. Surg. Res. |
pmid:11368530
|
Platta CS et al. |
The HDAC inhibitor trichostatin A inhibits growth of small cell lung cancer cells. |
2007 |
J. Surg. Res. |
pmid:17612559
|
Zhang Q et al. |
Trichostatin A protects against intestinal injury in rats with acute liver failure. |
2016 |
J. Surg. Res. |
pmid:27620992
|
To SQ et al. |
Epigenetic mechanisms regulate the prostaglandin E receptor 2 in breast cancer. |
2012 |
J. Steroid Biochem. Mol. Biol. |
pmid:22929011
|
Wu TH et al. |
Melatonin prevents neonatal dexamethasone induced programmed hypertension: histone deacetylase inhibition. |
2014 |
J. Steroid Biochem. Mol. Biol. |
pmid:25090636
|
Kim Y et al. |
Effects of acetylation, polymerase phosphorylation, and DNA unwinding in glucocorticoid receptor transactivation. |
2006 |
J. Steroid Biochem. Mol. Biol. |
pmid:16723222
|
Bao BY et al. |
Down-regulation of NF-kappaB signals is involved in loss of 1alpha,25-dihydroxyvitamin D3 responsiveness. |
2010 |
J. Steroid Biochem. Mol. Biol. |
pmid:20206692
|
Reichrath S et al. |
Notch- and vitamin D signaling in 1,25(OH)2D3-resistant glioblastoma multiforme (GBM) cell lines. |
2010 |
J. Steroid Biochem. Mol. Biol. |
pmid:20206691
|
Seuter S et al. |
The gene for the transcription factor BHLHE40/DEC1/stra13 is a dynamically regulated primary target of the vitamin D receptor. |
2013 |
J. Steroid Biochem. Mol. Biol. |
pmid:23220548
|
Banwell CM et al. |
Targeting 1alpha,25-dihydroxyvitamin D3 antiproliferative insensitivity in breast cancer cells by co-treatment with histone deacetylation inhibitors. |
2004 |
J. Steroid Biochem. Mol. Biol. |
pmid:15225779
|